Mycoplasma Testing Market, By Product Type (Mycoplasma Detection Kits, Reagents & Assays, and Reference Standards), By Technology, By Test Type, By Application, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4704
|
Published Date
February 2026
|
Pages
387
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Mycoplasma Testing Market size was valued at US$ 1,452.54 Million in 2024, expanding at a CAGR of 12.01% from 2025 to 2032.
Mycoplasma testing is critical for detecting and quantifying contamination in cell cultures, biologics, and pharmaceutical products, ensuring product safety and compliance with global regulatory standards. The growing demand for biologics, vaccines, and cell-based therapies is driving increased adoption of Mycoplasma testing solutions across research, development, and manufacturing laboratories.
Key growth opportunities lie in the development of rapid, high-sensitivity assays and automated testing platforms that reduce turnaround times while enhancing detection accuracy—an essential factor for maintaining quality in large-scale biopharmaceutical production. A notable trend is the integration of molecular and PCR-based techniques with traditional culture methods, which improves reliability and minimizes false negatives. Despite these advancements, the complexity of Mycoplasma detection and variability in test sensitivity continue to pose challenges, limiting adoption in small-scale laboratories and applications that require ultra-rapid or high-throughput testing.
Mycoplasma Testing Market- Market Dynamics
Increasing Demand for Contamination Control in Biopharmaceutical and Cell Therapy Production
The increasing adoption of biopharmaceuticals, vaccines, and cell-based therapies is driving strong demand for Mycoplasma testing solutions, which are essential for ensuring product safety, quality, and regulatory compliance. As manufacturers scale up production of biologics and therapeutic cell lines, there is a growing need for rapid, reliable, and sensitive Mycoplasma detection methods to prevent contamination that could compromise product efficacy and patient safety.
The shift toward high-throughput and automated testing platforms further supports market growth by enabling faster results, consistent accuracy, and seamless integration into modern biomanufacturing workflows. Additionally, the continuous expansion of global biologics production, particularly in regions such as North America and Europe, is increasing the demand for standardized and sensitive Mycoplasma testing. For example, recent data from 2024 shows that over 75% of biopharmaceutical manufacturers perform routine Mycoplasma testing across all cell-based production lines. The rising adoption of gene and cell therapies is also intensifying the need for robust contamination monitoring, ensuring adherence to stringent quality and regulatory standards.
Mycoplasma Testing Market- Segmentation Analysis:
The Global Mycoplasma Testing Market is segmented on the basis of Product Type, Technology, Test Type, Application, and Region.
The market is segmented by product type into mycoplasma detection kits, reagents & assays, and reference standards. Mycoplasma detection kits dominate the market due to their rapid, standardized, and validated solutions, which reduce both time and labor in testing workflows. These kits are essential for ensuring the safety and quality of biologics, vaccines, and cell culture-based products. Reagents and assays rank second, as they allow laboratories to customize detection protocols, support both manual and automated platforms, and achieve higher sensitivity and specificity across molecular and culture-based methods. Reference standards follow, providing critical quality control and calibration materials to ensure assay accuracy, reproducibility, and compliance with regulatory guidelines. Government agencies worldwide, including the U.S. FDA, European Medicines Agency (EMA), and Japan’s PMDA, mandate stringent mycoplasma testing standards in biologics production and research, with reports indicating that over 90% of licensed biopharmaceutical manufacturing facilities now employ validated kits and reference standards in compliance with regulatory oversight.
Based on technology, the market is categorized into PCR-based testing, ELISA, DNA staining, and microbial culture methods. PCR-based testing leads the segment due to its high sensitivity, rapid turnaround, and broad adoption in contamination monitoring and quality control workflows. ELISA ranks second, valued for its robust antigen–antibody detection capabilities, compatibility with high-throughput screening, and integration into automated QC processes. DNA staining methods are used primarily in research and specialized laboratory applications for visual detection of mycoplasma contamination, but they are less sensitive and more labor-intensive compared to molecular techniques. Microbial culture methods, though historically the standard, rank last due to slower turnaround times, lower throughput, and the need for specialized expertise, which limits their applicability in modern production and research environments. Global regulatory bodies emphasize the use of rapid, validated, and reproducible testing methods to safeguard public health, with national biologics and vaccine oversight programs reporting that over 70% of routine mycoplasma monitoring now relies on PCR or ELISA-based approaches.
Mycoplasma Testing Market- Geographical Insights
The Mycoplasma Testing Market exhibits distinct regional trends, with North America leading global demand due to its well-established biopharmaceutical sector, advanced laboratory infrastructure, and stringent regulatory requirements for contamination control, accounting for approximately 38–40% of the market share. The United States drives this dominance, as major therapeutic and vaccine manufacturers routinely incorporate Mycoplasma testing into quality control protocols.
Europe ranks second, supported by harmonized regulations and strong biotechnology research in countries such as Germany, the UK, and France, which promotes the adoption of rapid and reliable detection solutions. Meanwhile, the Asia-Pacific region is the fastest-growing market, fueled by expanding pharmaceutical and biologics production in China, India, and Japan, as well as increasing investments in automated testing platforms. Strategic initiatives further reinforce regional growth. For example, bioMérieux partnered with AnaBioTec in May 2024 to advance innovative Mycoplasma testing methodologies, while global expansion efforts by key market players are improving the accessibility of testing kits and services worldwide.
Mycoplasma Testing Market- Country Insights
At the country level, the United States remains the leading market for Mycoplasma testing, driven by its large biopharmaceutical industry, stringent regulatory standards for contamination control, and extensive R&D activity, which collectively support widespread adoption of advanced testing solutions. In 2024, North America accounted for nearly half of the global market, with the U.S. serving as the primary contributor. In Europe, key countries such as Germany, the United Kingdom, and France play a significant role, backed by strong research infrastructure and comprehensive contamination control initiatives in biologics and vaccine manufacturing.
The Asia-Pacific region, led by China, Japan, and India, is experiencing rapid growth as pharmaceutical and biopharmaceutical production expands and investment in quality control and automated testing platforms increases. China, in particular, is projected to see strong market growth due to its robust domestic biotech sector and rising adoption of standardized testing protocols. Strategic collaborations further enhance country-level capabilities. For example, bioMérieux partnered with AnaBioTec in 2024 to advance innovative Mycoplasma detection methods, strengthening testing accuracy and supporting broader adoption across national markets.
Mycoplasma Testing Market- Competitive Landscape:
The competitive landscape of the Mycoplasma Testing Market is characterized by a mix of established life science companies and specialized diagnostics providers offering contamination detection solutions. Leading players, including Merck KGaA, bioMérieux SA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., and Charles River Laboratories International Inc., compete based on test accuracy, speed, automation compatibility, and global distribution networks.
Companies are actively investing in assay development, automation integration, and expanded service offerings to strengthen their market positions. Strategic partnerships and acquisitions are reshaping competition: for example, bioMérieux partnered with AnaBioTec in 2024 to co-develop enhanced mycoplasma detection technologies, while Thermo Fisher Scientific’s acquisition of Qiagen’s Cell Culture and Molecular Diagnostics Business in 2023 expanded its infectious disease and contamination testing portfolio, including Mycoplasma solutions. Collaborations with contract research organizations (CROs) and genomic service providers further extend the reach of these testing platforms, supporting broad adoption in biopharmaceutical manufacturing and research laboratories. Overall, market dynamics are driven by innovation, regulatory compliance, and the provision of comprehensive testing solutions.
Recent Developments:
- September 2025: Fuse Diagnostics launched its Flip Mycoplasma rapid contamination test across major European countries through a distribution agreement with CliniSciences, enabling ultra-rapid, simple cell culture quality screening without complex equipment.
- April 2023: Agathos Biologics announced it would provide analytical testing services for life science researchers, exclusively using QIAGEN-developed QIAcuity equipment and assays. Additionally, Agathos and QIAGEN partnered to test and validate Mycoplasma and recombinant adeno-associated viral vector (rAAV) assays, strengthening service capabilities.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MYCOPLASMA TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Agilent Technologies
- ATCC
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Charles River Laboratories
- Creative Diagnostics
- Eurofins Scientific
- Fujifilm Irvine Scientific
- Hologic
- InvivoGen
- Lonza Group
- Merck KGaA
- Meridian Bioscience
- Minerva Biolabs
- PromoCell
- QIAGEN
- Roche Diagnostics
- Sigma-Aldrich
- Takara Bio
- Thermo Fisher Scientific
- Others
GLOBAL MYCOPLASMA TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Mycoplasma Detection Kits
- Reagents & Assays
- Reference Standards
GLOBAL MYCOPLASMA TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- PCR-Based Testing
- ELISA
- DNA Staining
- Microbial Culture Methods
GLOBAL MYCOPLASMA TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Qualitative Testing
- Quantitative Testing
GLOBAL MYCOPLASMA TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Cell Line Testing
- Vaccine Production Testing
- Biopharmaceutical Manufacturing
- Clinical Diagnostics
GLOBAL MYCOPLASMA TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Mycoplasma Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Mycoplasma Testing Market Snippet by Product Type
2.1.2. Mycoplasma Testing Market Snippet by Technology
2.1.3. Mycoplasma Testing Market Snippet by Test Type
2.1.4. Mycoplasma Testing Market Snippet by Application
2.1.5. Mycoplasma Testing Market Snippet by Country
2.1.6. Mycoplasma Testing Market Snippet by Region
2.2. Competitive Insights
3. Mycoplasma Testing Key Market Trends
3.1. Mycoplasma Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Mycoplasma Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Mycoplasma Testing Market Opportunities
3.4. Mycoplasma Testing Market Future Trends
4. Mycoplasma Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Mycoplasma Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Mycoplasma Testing Market Landscape
6.1. Mycoplasma Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Mycoplasma Testing Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Mycoplasma Detection Kits
7.1.3. Reagents & Assays
7.1.4. Reference Standards
8. Mycoplasma Testing Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. PCR-Based Testing
8.1.3. ELISA
8.1.4. DNA Staining
8.1.5. Microbial Culture Methods
9. Mycoplasma Testing Market – By Test Type
9.1. Overview
9.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
9.1.2. Qualitative Testing
9.1.3. Quantitative Testing
10. Mycoplasma Testing Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
10.1.2. Cell Line Testing
10.1.3. Vaccine Production Testing
10.1.4. Biopharmaceutical Manufacturing
10.1.5. Clinical Diagnostics
11. Mycoplasma Testing Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Mycoplasma Testing Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Mycoplasma Testing Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Mycoplasma Testing Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Mycoplasma Testing Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Mycoplasma Testing Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Mycoplasma Testing Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Agilent Technologies
12.2.2. ATCC
12.2.3. Becton, Dickinson and Company
12.2.4. Bio-Rad Laboratories
12.2.5. Charles River Laboratories
12.2.6. Creative Diagnostics
12.2.7. Eurofins Scientific
12.2.8. Fujifilm Irvine Scientific
12.2.9. Hologic
12.2.10. InvivoGen
12.2.11. Lonza Group
12.2.12. Merck KGaA
12.2.13. Meridian Bioscience
12.2.14. Minerva Biolabs
12.2.15. PromoCell
12.2.16. QIAGEN
12.2.17. Roche Diagnostics
12.2.18. Sigma-Aldrich
12.2.19. Takara Bio
12.2.20. Thermo Fisher Scientific
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MYCOPLASMA TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Agilent Technologies
- ATCC
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Charles River Laboratories
- Creative Diagnostics
- Eurofins Scientific
- Fujifilm Irvine Scientific
- Hologic
- InvivoGen
- Lonza Group
- Merck KGaA
- Meridian Bioscience
- Minerva Biolabs
- PromoCell
- QIAGEN
- Roche Diagnostics
- Sigma-Aldrich
- Takara Bio
- Thermo Fisher Scientific
- Others
GLOBAL MYCOPLASMA TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Mycoplasma Detection Kits
- Reagents & Assays
- Reference Standards
GLOBAL MYCOPLASMA TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- PCR-Based Testing
- ELISA
- DNA Staining
- Microbial Culture Methods
GLOBAL MYCOPLASMA TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Qualitative Testing
- Quantitative Testing
GLOBAL MYCOPLASMA TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Cell Line Testing
- Vaccine Production Testing
- Biopharmaceutical Manufacturing
- Clinical Diagnostics
GLOBAL MYCOPLASMA TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
